Trial Archives: Completed

---

Protocol SCT-MD-32, Forest Labs, Pediatric Depression

- March 24, 2011

Protocol E2007-G000-227, Eisai, Diabetic Peripheral Neuropathy

- March 24, 2011

Protocol E2007-A001-218, Eisai, Post Herpetic Neuralgia

- March 24, 2011

Protocol DepoMed81-0052 Open Label, PPD, Inc., Post Herpetic Neuralgia

- March 24, 2011

Protocol DepoMed81-0045, PPD, Inc., Post Herpetic Neuralgia

- March 24, 2011

Protocol C1538-3048-AD-US Open Label, Cephalon, Attention Deficit Hyperactive Disorder

- March 24, 2011

Protocol C6671a-302-PT-US, Cephalon, Post Traumatic Stress Disorder

- March 24, 2011

Protocol C1538d-312-AD-US, Cephalon, Attention Deficit Hyperactive Disorder

- March 24, 2011

Protocol C1538d-309-AD-US, Cephalon, Attention Deficit Hyperactive Disorder

- March 24, 2011

Protocol BCX1812-311, BioCryst, Influenza

- March 24, 2011

Protocol BCX1812-211, BioCryst, Influenza

- March 24, 2011

Protocol AVI-4065-20, AVI BioPharma, Hepatitis C

- March 24, 2011

Protocol AVI-4020-14, AVI BioPharma, West Nile Virus

- March 24, 2011

Protocol 04-AV-109, Avanir, Painful Diabetic Neuropathy

- March 24, 2011

Protocol 05-0-223, Astellas, Diabetic Neuropathy

- March 24, 2011